Navigation Links
Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection

MARKHAM, ON, June 28, 2007 /PRNewswire/ - Cytochroma Inc. announced today positive data from a Phase I clinical trial of CTA018 Injection. The initial top-line results from this trial showed that CTA018 was safe and well tolerated. Complete study results are expected in August 2007.

The recently completed Phase I trial was an open label, placebo-controlled, randomized study of CTA018 Injection administered to 20 healthy volunteers. In this trial, the safety of CTA018 Injection was evaluated after single doses of up to 180 mcg. Placebo and two strengths of CTA018, 90 mcg and 180 mcg, were subsequently studied during repeated dose administration. The trial was conducted at a single Canadian center. Key safety evaluations included adverse events, serum and urine calcium, serum ionized calcium and serum phosphorus. No drug-related adverse events were reported.

Significant reduction in the blood levels of parathyroid hormone (PTH) was observed in this trial, suggesting that CTA018 has potential as a treatment for secondary hyperparathyroidism in chronic kidney disease (CKD). Blood samples collected before and after repeated CTA018 administration documented a mean reduction in PTH level of more than 20% after five doses of 180 mcg.

"While this safety trial was not designed to demonstrate efficacy, we were pleasantly surprised to see a significant reduction of PTH levels after just a few doses of CTA018," stated Dr. Jukka Karjalainen, Executive Director, Product Development. "As expected, we did not see any elevations in serum or urine calcium or in serum phosphorus. Serum ionized calcium levels also remained unchanged. We believe that the PTH-lowering effect of CTA018 will be even more pronounced in CKD patients with secondary hyperparathyroidism."

About CTA018

CTA018 is the first compound in a new class of active Vitamin D analogs having a novel dual mechanism of action. CTA018 is
'"/>




Page: 1 2 3

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
8. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
9. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
10. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
11. Bentley Reports Positive Results with Nasulin Intranasal Insulin Spray at the American Diabetes Association Meeting
Post Your Comments:
(Date:7/31/2014)... , July 31, 2014  Decision Resources ... brought about by the Affordable Care Act ... prescribing of pharmaceutical therapies. The ACA altered ... through new regulations and expanded access via ... the health exchanges—state-based marketplaces set up by ...
(Date:7/31/2014)... , July 31, 2014 Touro University California,s ... been selected as the recipient of a $150,000 grant ... allow the University to increase research and classroom space ... state-of-the-art technology for the study of health sciences, and ... diverse needs and interests of our students," said ...
(Date:7/31/2014)... 31, 2014 For its innovative modular Biomedical ... , Art,s-Way Scientific has earned a Modular Building Institute ... in over 30 categories, MBI,s contest is the commercial ... include building manufacturers, dealers, and product and service providers. ... the capability of our team," said Dan Palmer ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Touro University California Garners Grant From Long Foundation 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
... Institute, the leading provider of specialized training solutions ... subsidiary of Campbell Alliance, announced today the completion ... Area Essentials™ e-course series.  This series ... biotech R&D and commercial professionals.  It includes 155 ...
... Calif., June 20, 2011 Inogen has been honored ... the Inogen One Portable Oxygen Concentrator.  The Medical Design ... exclusively recognizes contributions and advances in the design of ... by Goleta, California based Inogen, Inc. is used to ...
Cached Medicine Technology:Therapeutic Area Essentials "Class of 2011" Brings Current Disease State Training to Pharma 2Inogen One Wins Gold Medical Design Excellence Award 2
(Date:8/1/2014)... A new study published in ... contribute to the development of colorectal cancer in patients ... study was authored by Alberto Martin of the University ... intestinal cells to multiply and create tumors in mice ... , “What’s interesting about this study,” said Shahab Mehdizadeh, ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Narconon Arrowhead ... the program at the drug rehab center located in ... year 2001, Narconon Arrowhead is the flagship drug rehab ... across the United States for services there. Now, with ... has recent outcome studies as well as client reviews ...
(Date:8/1/2014)... Albany, New York (PRWEB) August 01, 2014 ... intelligence firm, recently announced the addition of a ... The report, titled ‘Infusion System Market (Large Volume, ... Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... the company’s website http://www.transparencymarketresearch.com . , To ...
(Date:8/1/2014)... By Tara Haelle ... -- A home-packed lunch isn,t necessarily healthier than school cafeteria ... that just 27 percent of the lunches third and fourth ... Lunch Program (NSLP) standards. , , "Our findings are similar ... across the world, which have found that high-calorie packaged foods ...
(Date:8/1/2014)... -- Although older women with asthma often have worse health ... to a new study. "There is no doubt that ... over 65," concluded Dr. James Sublett, an allergist and president-elect ... in an organization news release. In fact, the asthma ... nearly four times higher than in other groups of people, ...
Breaking Medicine News(10 mins):Health News:Carbs May Contribute to Colon Cancer 2Health News:Narconon Arrowhead Celebrates 4,300th Graduate from Program 2Health News:Narconon Arrowhead Celebrates 4,300th Graduate from Program 3Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 2Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 3Health News:Older Women With Asthma Face Worse Health Outcomes 2
... to be worst hit by the bird flu, have confirmed ... disease //in Shanxi province on Monday. ,The officials ... identified after an indefinite number of chickens died in poultry ... they have sent the samples of the dead birds to ...
... restrictions that are to be placed on advertising junk food ... games, cinemas, packaging, and school sponsorship. Reports also indicate that ... the use of loyalty cards in store, so that healthy ... contain high levels of salt, fat and sugar. ...
... to a report put forth on ... nursing education of Witwatersrand University, ... to suffer from anemia and elevated ... pregnancy and eventually deliver babies with ...
... new way of freezing human eggs which will be a blessing ... able to have children. , ,Women’s eggs are very delicate ... to sperms which can be easily frozen and thawed. ... researchers which hold promise over the present technique being used. ...
... for health in Andhra Pradesh, the state has recorded the highest ... rate is stuck at 62 per 1000 live births for the ... very slow rate and perhaps will take another decade to touch ... Pradesh back in the achievement of the millennium development goals targeted ...
... in Sydney have identified a cue to detect depth in motion. ... is dynamic //half-occlusion. This is helpful in achieving a perception of ... a free access on Association for Research in Vision and Ophthalmology ... established by Leonardo da Vinci, Drs.Kevin Brooks and Barbara Gillam of ...
Cached Medicine News:Health News:Junk Food Advertisements To Be Restricted In All Forms of Media 2
... The Forceps Are Available In Two Models: ... Are Compressed, The Jaws Close. The Other ... The Handles Are Compressed The Jaws Open., ,The ... To Be Inserted Through A 1.1mm Incision. These ...
... Turned 90 Degrees To Allow Full ... Incising Tissue. ,Special Mirror-Polished Double Footplate Construction ... Extension Settings Of 0.5mm, 0.55mm, 0.6mm, ... Wide Snub Nose Diamond Blade Is ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
2.5V Halogen source, fiber-optic delivery, 3X magnification, pocket-sized....
Medicine Products: